Article Information
- Received April 28, 2014
- Revision received October 27, 2014
- Accepted October 30, 2014
- First published December 3, 2014.
- Version of record published December 3, 2014.
Author Information
- 1Department of Cell Biology, Howard Hughes Medical Institute and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, Connecticut 06510,
- 2European Neuroscience Institute (ENI), 37077 Göttingen, Germany, and
- 3Department of Experimental Medicine, University of Genoa, 16132 Genoa, Italy
Author contributions
Author contributions: M.C., I.M., S.G., and P.D.C. designed research; M.C., I.M., and S.G. performed research; M.C., I.M., S.G., and P.D.C. analyzed data; M.C. and P.D.C. wrote the paper.
Disclosures
- Received April 28, 2014.
- Revision received October 27, 2014.
- Accepted October 30, 2014.
This work was supported in part by the grants from the National Institutes of Health (R37NS03625), the Ellison Foundation, and the Michael J. Fox Foundation (No. 8954) to P.D.C.; and a postdoctoral fellowship from the American Parkinson disease Association to M.C. We thank Lijuan Liu, Louise Lucast, Heather Czapla, Melanie König, and Frank Wilson for superb technical assistance and Mirko Messa for the gift of purified GST proteins. We are also grateful to Dr. Lois Weisman (University of Michigan) for the gift of Vac14 brain tissues and antibody and to Dr. Jun Xia (Hong Kong University of Science and Technology) for the gift of myc-Parkin plasmid.
The authors declare no competing financial interests.
- Correspondence should be addressed to Pietro De Camilli, Department of Cell Biology, Howard Hughes Medical Institute and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510. pietro.decamilli{at}yale.edu